Dipeptidyl Peptidase IV (DP IV, CD26) in Patients with Inflammatory Bowel Disease

References

• Strober W, Fuss IJ, Ehrhardt RO, Neurath M, Boirivant M, Ludviksson BR. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol 1998;48:453–8.
   PubMed Web of Science ®Google Scholar
• Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol Today 1994;15:180–4.
   PubMedGoogle Scholar
• Tanaka T, Duke Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF, et al. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 1994;91:3082–6.
   PubMed Web of Science ®Google Scholar
• Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 1997;186:1865–72.
   PubMed Web of Science ®Google Scholar
• Proost P, Struyf S, Schols D, Durinx C, Wuyts A, Lenaerts JP, et al. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1 alpha. FEBS Lett 1998;432:73–6.
   PubMed Web of Science ®Google Scholar
• Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, et al. Amino-terminal truncation of chemokines by CD26/ dipeptidylpeptidase IV. Conversion of rantes into a potent inhibitor of monocyte chemotaxix and HIV-1-infection. J Biol Chem 1998;273: 7222–7.
   Google Scholar
• Bauvois B, Sanceau J, Wietzerbin J. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha. Eur J Immunol 1992;22: 923–30.
   Google Scholar
• Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, et al. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 1999;162: 4903–9.
   Google Scholar
• Willheim M, Ebner C, Baier K, Kern W, Schrattbauer K, Thien R, et al. Cell surface characterization of T lymphocytes and allergen-specifi c T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol 1997;100:348–55.
   PubMed Web of Science ®Google Scholar
• Hildebrandt M, Reutter W, Arck P, Rose M, Klapp BF. A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence. Clin Sci (Colch) 2000;99:93–104.
   Google Scholar
• Scharpé S, De Meester I, Vanhoof G, Hendriks D, Uyttenbroek W, Ntakarutimana V, et al. Serum dipeptidyl peptidase IV activity in transplant recipients. Clin Chem 1990;36:984.
   Google Scholar
• Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH, et al. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 1997;63:1495–500.
   PubMed Web of Science ®Google Scholar
• Best WR, Becktel JM, Singleton JW, Kern DF. Development of Crohn’s Disease Activity Index. Gastroenterology 1976;70:439–44.
   PubMed Web of Science ®Google Scholar
• Kreisel W, Heussner R, Volk B, Büchsel R, Reutter W, Gerok W. Identification of the 110000 Mr glycoprotein isolated from rat liver membrane as dipeptidylaminopeptidase IV. FEBS Lett 1982;147: 85.
   Google Scholar
• Juillerat Jeanneret L, Aubert JD, Leuenberger P. Peptidases in human bronchoalveolar lining fluid, macrophages; and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme). J Lab Clin Med 1997;130:603–14.
   Google Scholar
• Uematsu T, Urade M, Yamaoka M, Yoshioka W. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 1996;25:507–12.
   PubMed Web of Science ®Google Scholar
• Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, et al. Alterations in expression and in serum activity of Dipeptidyl Peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scand J Immunol 1999;50: 536–541.
   Google Scholar
• Gotoh H, Hagihara M, Nagatsu T, Iwata H, Miura T. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Chem 1989;35:1016–8.
   Google Scholar
• Mizutani T, Mizutani H, Kaneda T, Hagihara M, Nagatsu T. Activity of dipeptidyl peptidase II and dipeptidyl peptidase IV in human gingiva with chronic marginal periodontitis. Arch Oral Biol 1990;35:891–4.
   Google Scholar
• Muscat C, Bertotto A, Agea E, Bistoni O, Ercolani R, Tognellini R, et al. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 1994;98:252–6.
   PubMed Web of Science ®Google Scholar
• Stancikova M, Lojda Z, Lukac J, Ruzickova M. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1992;10:381–5.
   PubMed Web of Science ®Google Scholar
• Plana M, Font J, Vinas O, Martorell J, Ingelmo M, Vives J. Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen. Clin Immunol Immunopathol 1994;72:227–32.
   PubMedGoogle Scholar
• Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR. Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 1993;142:1610–21.
   Google Scholar
• Mizokami A, Eguchi K, Kawakami A, Ida H, Kawabe Y, Tsukada T, et al. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis. J Rheumatol 1996;23:2022–6.
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359–67.
   Google Scholar
• Maes M, Meltzer HY, Scharpe S, Bosmans E, Suy E, De Meester I, et al. Relationships between lower plasma Ltryptophan levels and immune-inflammatory variables in depression. Psychiatry Res 1993;49:151–65.
   Google Scholar
• Kaneko H, Saito K, Hashimoto H, Yagita H, Okumura K, Azuma M. Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol 1996;106:218–29.
   PubMed Web of Science ®Google Scholar